• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA Grants 510(k) Clearance to LivaNova’s B-Capta

    Gynesonics Appoints Susan Stimson to Its Board of Directors

    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump

    Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology

    Abbott Begins Shipping Rapid COVID Self-Tests
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Qosina Corp.

    MW Life Sciences

    PTI Engineered Plastics Inc.

    Forefront Medical Technology

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EMS' Engineering Resources Increasingly in Demand

    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    Medbio LLC

    FUTEK Advanced Sensor Technology Inc.

    Unicep

    Trademark Plastics Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    COVID-19’s Impact on the Medical Device Supply Chain

    ...

    Tony Freeman, President, A.S. Freeman Advisors LLC04.01.20
    On March 11, the World Health Organization declared COVID-19 a global pandemic, prompting the shutdown of much of civilized life. Conventional wisdom holds that medtech companies are largely insulated from economic disruption due to the steady demand for medical products and procedures. This notion, however, could be turned on its head as hospitals delay elective procedures in order to free up space for critically ill virus patients. A careful review of all the issues associated with the pandemic shows that COVID-19 will have numerous short-, mid-, and long-term impacts on the medical device industry. Companies that operate regularly in the supply chain should expect to see the emergence of stronger, more conservatively financed, multi-site suppliers as a long-term outcome of the pandemic.

    Where to Find Guidance
    The fast-moving, evolving coronavirus pandemic guarantees challenges for businesses worldwide. As managers plan to ride out the disruption, many are finding they have no point of reference around which to organize their efforts. While supply chain executives have lived through banking crises, slowdowns, staff shortages, and even weather emergencies, few alive today have lived through a rapidly spreading health disaster. Where should a manager look to understand how the disruption is unfolding and how it will hit their company’s segment of the medical device industry? Traditionally, the supply chain has looked to OEM sales as the best indicator of industry outlook. In this situation, it is more useful to look beyond the OEMs to their customers—the hospitals, clinics, and physicians that comprise the provider segment—as the first movers that will set in motion the chain of events to which suppliers must react.

    As the coronavirus crisis expands, providers are rapidly shifting their practice and purchasing priorities to meet the demands of a pandemic. Two changes in the coming months seem certain: The first is that medical staff and equipment will be shifted to fight the virus and its complications. Doctors, nurses, hospital rooms, diagnostic labs, and capital equipment will be shifted from traditional uses to screening and treating coronavirus patients. The second is that critical procedures will still take place, though with some minor delays for the less time-sensitive treatments. Non-critical procedures will be delayed or cancelled for the foreseeable future. These are only two of the changes likely to occur in the coming weeks. Still, we can project their short-term, mid-term, and long-term impact on the supply chain.

    Short-Term Impacts: Commercial
    Over the next six months, there will be a series of demand shocks, both positive and negative, as medical device OEMs and their suppliers respond to providers’ changing needs. Beneficiaries of the epidemic will be vendors of basic hospital supplies, as healthcare facilities fill to capacity with coronavirus victims. Many of these products will be low-margin disposables including masks, wipes, disposable hospital room products, and standard examination supplies. Demand for these products should increase markedly for a few weeks but a robust supplier base will be able to rapidly ramp to meet demand. Also benefiting from demand but more constrained in capacity will be manufacturers of diagnostic consumables and imaging suppliers as more patients are tested for coronavirus and those diagnosed are tracked for respiratory issues.

    Beyond these “front and center” products, an area likely to be tested by the pandemic will be telehealth devices and services. For the next few months, this product class—largely considered a novelty or luxury up until now—has the opportunity to demonstrate real value as traditional healthcare services become overwhelmed by patient load demands.

    Will the financial impact of these increases in demand be significant? With the exception of the diagnostics companies selling coronavirus tests, the uptick in device demand will be modest when compared against the broadly diversified product portfolios of the OEM suppliers. A few companies will garner higher sales in a few product lines, many of which are low-margin commodity products. The overall impact will not be exceptional, however.

    In the short-term, demand will decline across the rest of the device industry. Manufacturers of critical devices and components will experience a modest slowdown in orders for two reasons. Device management executives at OEMs responsible for established products will be uncertain as to demand, given the rapidly evolving news about the numbers of infected and disruptions affecting medicines and devices. Thus, they will tightly manage inventories. Reorders will take place, though at a slower pace as OEMs strive to understand the full impact of the virus on their businesses. Managers overseeing new product launches will also act more slowly, hesitant to make bold moves in uncertain times. The impact of both these trends will prove operationally disruptive to suppliers but should have only a modest revenue impact in 2020 for OEMs.

    OEMs of non-critical devices and their suppliers will face greater challenges in the coming months. No area of medicine will be impacted by demand shock as much as orthopedics. Orthopedic procedures are rarely considered critical and often have long recovery periods, requiring several trips to healthcare facilities. The possibility of multiple interactions with providers at institutions handling coronavirus cases will cause potential patients to choose ibuprofen over surgery. The orthopedic problem is compounded by the economic disruption certain to be caused by the virus. As stated, orthopedic procedures often have long recovery times; with the possibility of a recession looming, workers fearful of possible layoffs will be hesitant to take extended time off for joint replacement procedures or spinal fusions. Amplifying these delays in surgeries is the fact that orthopedic OEMs, by the very nature of their product lines, have significantly more inventory than a comparably sized non-orthopedic OEM. As was the case in the 2008 recession, orthopedic companies are quick to manage inventory in down times. The orthopedic supply chain should brace itself for a sharp drop in orders over several months. OEMs specializing in “quality of life” areas of medicine including aesthetic surgery and ophthalmology will also experience a decline in orders.

    Mid-Term Impacts: Financial
    As demand shocks make their way to OEMs and through the supply chain, financial strains will emerge. Over the next 12 months, deferred and diminished orders will show up as cash flow issues, particularly at smaller suppliers and heavily leveraged companies. Bankruptcies are unlikely but constrained cash will limit the operational freedom many OEMs and supply chain companies have enjoyed in recent years. Some companies will slow down hiring and/or defer capital projects.

    Specific financial impacts will vary by area of medicine and by company. As with orthopedics, inventory management will become an increasingly important area of focus to manage cash and resources. Firms with exceptional debt loads may find themselves in discussions with their lenders regarding challenges in meeting bank covenants. Still, the cash flow effects brought on by the epidemic are likely to be limited to three to nine months as companies make difficult cuts to ensure profitable operation.

    Long-Term Impacts: Strategic
    The 2020 coronavirus pandemic will cause OEMs to reevaluate their supplier lists. The most well-known afflictions of the latter 20th century—polio, HIV, malaria, Ebola—were either limited to specific areas or concentrated in populations that device companies rarely served. Not surprisingly, the criterion “supplier is able to provide product reliably despite irregular orders and local sick outs” has not been on the checklist for selecting preferred vendors. In the coming years, OEM procurement teams will consider which suppliers are best suited to survive and supply products in the face of global health issues. Other reactions to the pandemic experience will include an increase in dual sourcing of key components and a preference for larger, more financially stable suppliers with multiple manufacturing sites. These biases will present new challenges for smaller and more leveraged companies, regardless of their expertise. Which firms will be affected? Assume supply chain managers at OEMs will draw their lessons from the worst cases of disruption or perceived instability.

    The Best Approach: Demonstrate Stability in Unstable Times
    As the device industry navigates unchartered and choppy waters, supply chain managers might want to consider how best to present their firms to customers. Suppliers should recognize that OEMs may be dealing with market disruptions. They may not be able to provide accurate information or lead the relationship in the ways they have in more stable times. Rather than ignore or complain about uncertainty, suppliers will be well-served if they can demonstrate plans that show customers they can reliably manufacture regardless of societal disruptions. One action should include calls with customers on how the supplier intends to operate over the next several months. Will production be handled in the traditional way? Will it be shifted to other facilities if needed? Are additional quality steps being considered? Will the supplier’s workforce be screened and offered care if required? Will hours change to accommodate closed schools and daycare? It is essential to show a plan, not “We are trying our best.”

    Suppliers should manage the perception of their readiness to adapt to changing situations. Those that demonstrate competence will be rewarded as their customers look back in the coming years. 


    Tony Freeman is the president of the A.S. Freeman Advisors LLC in New York City. He advises on mergers and acquisition in the specialty materials and precision manufacturing industries. A.S. Freeman Advisors provides a corporate strategy, market planning, and valuation improvement consulting services. Freeman can be contacted at tfreeman@asfreeman.com
    Related Searches
    • sales
    • first
    • it
    • company

    Related Columns

    • Cardiovascular | Surgical
      Home Is Where the Heart (Valve) Is

      Home Is Where the Heart (Valve) Is

      Artificial heart valve makers reached a number of milestones despite the pandemic’s global squeeze.
      Sam Brusco, Associate Editor 04.01.21

    • Chronic Disease | Digital Health | Patient Monitoring
      CGM: Digital Health Meets a Very Large Opportunity

      CGM: Digital Health Meets a Very Large Opportunity

      Continuous glucose monitors (CGMs) are one of the most formidable diabetes management tools to be developed in decades.
      Maria Shepherd, President and Founder, Medi-Vantage 04.01.21

    • Surgical
      Biomechanical Engineer, Heal Thyself

      Biomechanical Engineer, Heal Thyself

      Choosing a treatment option for spinal disorders can be tricky with extensive knowledge of the industry.
      Dawn A. Lissy, Founder & President, Empirical 04.01.21


    • Molding | Surgical
      Optimizing MIM in Medical Device Manufacturing

      Optimizing MIM in Medical Device Manufacturing

      Metal injection molding (MIM) is a good choice for producing medium- to high-volume medtech parts.
      Steve Santoro, Executive Vice President, MICRO 04.01.21

    • Diagnostics
      PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market

      PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market

      With smart onshoring strategies, the medical device industry can collaborate to fix supply chain issues.
      Claudio Hanna and Ralph Tricomi , Web Industries 04.01.21

    • Testing
      The Evolution of Chemical Characterization for Medical Devices

      The Evolution of Chemical Characterization for Medical Devices

      Evaluation of biological safety of devices is experiencing some of the most significant changes in history.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec Medical Device Testing 04.01.21


    • Digital Health
      How Digital Health Fits into the Medtech Mold

      How Digital Health Fits into the Medtech Mold

      Healthcare will need to adopt digital technologies that streamline and enhance connectivity.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 04.01.21

    • Global Supply Chain Wisdom from Coronavirus-Colored Lenses

      Global Supply Chain Wisdom from Coronavirus-Colored Lenses

      There are precious pearls of wisdom from this past year that will come in handy during the next “crisis.”
      Chris Oleksy, Founder and CEO, Oleksy Enterprises and Co-Founder Next Life Medical; CEO, Emergent Respiratory 04.01.21

    • Four Considerations When Selling to a Private Equity Fund

      Four Considerations When Selling to a Private Equity Fund

      A private equity partner can help medtech firms expand into new markets and serve existing clients better.
      Bill Hadler and Anisa Mohanty, McDermott Will & Emery 04.01.21


    • Software & IT
      Cybersecurity Compromises, Courtesy of COVID-19

      Cybersecurity Compromises, Courtesy of COVID-19

      As the healthcare industry focused its energies last year on battling SARS-CoV-2, cybercriminals used the distraction to their advantage.
      Michael Barbella, Managing Editor 03.04.21

    • A Look at the Actual Device Costs for Hospitals

      A Look at the Actual Device Costs for Hospitals

      According to a 2018 clinical journal article, U.S. hospitals spent approximately $200 billion on medical devices.
      Maria Shepherd, President and Founder, Medi-Vantage 03.04.21

    • Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

      Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

      For small businesses, trade shows are a critical part of developing new business as well as maintaining contacts.
      Dawn A. Lissy, Founder & President, Empirical 03.04.21


    • FDA Making Progress With Technology and Data Action Plans

      FDA Making Progress With Technology and Data Action Plans

      There is an urgent need to get advanced technologies into the healthcare ecosystem, but all products must first get regulatory approval.
      Alan Rencher, Vice President, Engineering, MasterControl 03.04.21

    • What’s Hot Now in Medtech M&A

      What’s Hot Now in Medtech M&A

      Every M&A cycle in the life sciences/medtech sector fosters exciting deals that interestingly impact the industry in both the short and long term.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 03.04.21

    • Software & IT
      Three Ways to Fast-Track the Total Product Lifecycle

      Three Ways to Fast-Track the Total Product Lifecycle

      Here are three ways leaders including Alcon, Baxter Healthcare, Boston Scientific, Epredia, and Illumina are driving innovation in medtech.
      Seth Goldenberg, Ph.D., Vice President, MedTech, Veeva Systems 03.04.21


    Trending
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Harnessing Critical Health Data With Wearable Technology
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    • Gynesonics Appoints Susan Stimson to Its Board of Directors
    • Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    • Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology
    • Abbott Begins Shipping Rapid COVID Self-Tests
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Longvida Curcumin Extract Receives ANVISA Approval in Brazil
    Curcugen Curcumin Formulation Evidenced to Attenuate Post-Exercise Inflammation
    Good Rāz Launches Taste-Free Vitamin D3 Drops
    Coatings World

    Latest Breaking News From Coatings World

    USGBC Releases Results of 2021 Green Building Community Survey
    PPG Publishes Sustainability Report
    Sherwin-Williams Launches Echelon
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    Gynesonics Appoints Susan Stimson to Its Board of Directors
    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Evotec to Build Second Biologics Mfg. Facility in Toulouse
    Adare Pharma Names Ludger Roedder President of Adare Biome
    Johnson & Johnson 1Q Results
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Donginbi Launches Men’s Skincare Collection
    Kiehl’s Launches Pouch Refillables
    Skin Match Technology Partners with Men-Only Grooming Platforms
    Happi

    Latest Breaking News From Happi

    Robertet Appoints Reichert as Perfumer
    Kiehl’s Launches Sustainable Pouch Refillables for Hair Care, Skin Care
    New OTC Natural Hemp Pain Relief Gel Arrives at cbdMD
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PPG releases 2020 Sustainability Report
    GAA merges with AIMCAL
    Acucote expands Insights educational program
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Glatfelter GlatClean Nominated for World of Wipes Innovation Award
    P&G’s Sales Up 5%
    Ontex Tests Industrial Scale Diaper Composting
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Spinal Elements' Lucent 3D Additive Manufactured Interbodies Earn FDA Nod
    Conformis, Paragon 28 Ink Licensing Deal
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints imec, Soitec Executives to Europe Advisory Board
    NREL Takes Novel Approach to 3D-Printed Water Power Prototypes
    Canatu Manufactures World’s Thinnest Free-standing CNB Membrane

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login